Parkman Healthcare Partners LLC Codexis, Inc. Transaction History

Parkman Healthcare Partners LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$6.06 - $12.86 $598,303 - $1.27 Million	-98,730 Reduced 48.39%	105,319 $638,000
Q2 2022 Aug 12, 2022	SELL	$8.35 - $21.89 $535,193 - $1.4 Million	-64,095 Reduced 23.9%	204,049 $2.13 Million
Q1 2022 May 13, 2022	SELL	$16.97 - $31.93 $1.22 Million - $2.3 Million	-72,008 Reduced 21.17%	268,144 $5.53 Million
Q4 2021 Feb 11, 2022	BUY	$25.61 - $41.78 $1.39 Million - $2.26 Million	54,085 Added 18.91%	340,152 $10.6 Million
Q3 2021 Nov 12, 2021	BUY	$19.65 - $27.99 $1.57 Million - $2.24 Million	80,000 Added 38.82%	286,067 $6.65 Million
Q2 2021 Aug 13, 2021	BUY	$17.48 - $25.46 $1.85 Million - $2.7 Million	106,067 Added 106.07%	206,067 $4.67 Million
Q1 2021 May 14, 2021	BUY	$18.08 - $28.8 $1.81 Million - $2.88 Million	100,000 New	100,000 $2.29 Million

144

60.6M

68.5K

20.1K

Ticker CDXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,494,100
Market Cap $274M
Description
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Parkman Healthcare Partners LLC with notifications on news.